Celltrion
068270.KS
#770
Rank
S$34.60 B
Marketcap
$167.07
Share price
1.34%
Change (1 day)
-4.84%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.08

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $4.01. In 2022 the company made an earnings per share (EPS) of $3.91 a decrease over its 2021 EPS that were of $4.64.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.084.52%
2022$3.91-15.84%
2021$4.6412.77%
2020$4.1270.79%
2019$2.4115.63%
2018$2.08-33.13%
2017$3.12141.17%
2016$1.298.28%
2015$1.1911.28%
2014$1.0716.37%
2013$0.92-67.42%
2012$2.8384.22%
2011$1.5462.13%
2010$0.9580.61%
2009$0.52-559.63%
2008-$0.11-123.16%
2007$0.49